MoneyWorks4Me

Astal Laboratories - Quaterly Results

24 May 2024 Evaluate
The total revenue surged to Rs. 122.52 millions, up 257.41% for the March 2024 quarter as against Rs. 34.28 millions during the year-ago period.The Total revenue for the quarter ended March 2024 of  Rs. 5.58  millions  grew by 481.25% from Rs. 0.96 millions.The company reported a good operating profit of 5.78 millions compared to 1.16 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 122.52 34.28 257.41 236.48 34.28 589.85 236.48 34.28 589.85
Other Income 0.00 0.94 -100.00 0.13 1.79 -92.74 0.13 1.79 -92.74
PBIDT 5.78 1.16 398.28 11.17 0.40 2692.50 11.17 0.40 2692.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 5.78 1.16 398.28 11.17 0.40 2692.50 11.17 0.40 2692.50
Depreciation 0.20 0.04 400.00 0.30 0.08 275.00 0.30 0.08 275.00
PBT 5.58 1.12 398.21 10.87 0.32 3296.88 10.87 0.32 3296.88
TAX 0.00 0.16 0.00 3.02 0.16 1787.50 3.02 0.16 1787.50
Deferred Tax 0.00 0.06 0.00 0.08 0.06 33.33 0.08 0.06 33.33
PAT 5.58 0.96 481.25 7.85 0.16 4806.25 7.85 0.16 4806.25
Equity 98.46 39.00 152.46 98.46 39.90 146.77 98.46 39.90 146.77
PBIDTM(%) 4.72 3.38 39.41 4.72 1.17 304.78 4.72 1.17 304.78
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..